Medical Condition

brain metastases adult

Total Trials

8

Recruiting Now

8

Trial Phases

Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for brain metastases adult sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — brain metastases adult Clinical Trials

How many clinical trials are currently recruiting for brain metastases adult?

ClinicalMetric currently tracks 8 actively recruiting clinical trials for brain metastases adult, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for brain metastases adult?

brain metastases adult research spans Phase 1 (1 trial), Phase 2 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a brain metastases adult clinical trial?

Eligibility criteria for brain metastases adult trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Top Sponsors

Ayal A. Aizer, MD 2 trials

Baptist Health South Florida 1 trial

Imperial College London 1 trial

Second Affiliated Hospital, Zhejiang University, School of Medicine 1 trial

Susanne Rogers 1 trial

Recruiting Clinical Trials

NCT07130786 Phase 2

Recruiting

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery

Baptist Health South Florida

View Trial →

NCT06611306

Recruiting

BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy.

Imperial College London

View Trial →

NCT07198256

Recruiting

AI-assisted Diagnosis of Malignant Brain Tumors

Second Affiliated Hospital, Zh...

View Trial →

NCT07132190 Phase 2

Recruiting

Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction

Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases

Enrollment

200 pts

Location

Austria, Germany, Sw...

Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases

a Feasibility Study of iHD-SRT for BM

Related Conditions

brain metastases from non small cell lung cancer nsclc (2) brain metastases from extra cranial solid tumors (2) brain metastases (2) seizures (1) primary motor cortex (1) brain cancer (1) breast cancer (1) gliomas (1) lymphoma (1) brain tumor adult (1) brain tumor metastatic (1) stereotactic radiotherapy (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology